CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 209 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $201,221 | -2.8% | 9,290 | -45.8% | 0.00% | -100.0% |
Q4 2019 | $207,000 | +16.3% | 17,130 | +28.2% | 0.00% | 0.0% |
Q4 2018 | $178,000 | -66.8% | 13,360 | -65.1% | 0.00% | -50.0% |
Q3 2018 | $536,000 | +11.2% | 38,246 | +24.7% | 0.00% | 0.0% |
Q2 2018 | $482,000 | -6.9% | 30,660 | -2.6% | 0.00% | 0.0% |
Q1 2018 | $518,000 | +5.5% | 31,482 | +15.9% | 0.00% | 0.0% |
Q4 2017 | $491,000 | +68.2% | 27,161 | +79.7% | 0.00% | +100.0% |
Q3 2017 | $292,000 | +2554.5% | 15,112 | +1557.0% | 0.00% | – |
Q2 2017 | $11,000 | +10.0% | 912 | 0.0% | 0.00% | – |
Q1 2017 | $10,000 | +25.0% | 912 | -18.0% | 0.00% | – |
Q4 2016 | $8,000 | +14.3% | 1,112 | +2.4% | 0.00% | – |
Q3 2016 | $7,000 | +40.0% | 1,086 | +19.1% | 0.00% | – |
Q2 2016 | $5,000 | +25.0% | 912 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | -20.0% | 912 | 0.0% | 0.00% | – |
Q4 2015 | $5,000 | +66.7% | 912 | 0.0% | 0.00% | – |
Q3 2015 | $3,000 | -40.0% | 912 | 0.0% | 0.00% | – |
Q1 2015 | $5,000 | +66.7% | 912 | 0.0% | 0.00% | – |
Q4 2014 | $3,000 | – | 912 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |